IDEX Biometrics ASA
IDXAF
$0.89
$0.69345.00%
OTC PK
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 161.74% | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 161.74% | -- | |||
| Cost of Revenue | -83.47% | 5,662.50% | |||
| Gross Profit | 126.63% | -4,800.00% | |||
| SG&A Expenses | 114.54% | 9.90% | |||
| Depreciation & Amortization | -47.68% | -47.73% | |||
| Other Operating Expenses | 4.01% | 5.74% | |||
| Total Operating Expenses | 30.92% | 4.09% | |||
| Operating Income | -26.39% | -0.61% | |||
| Income Before Tax | -41.10% | -181.85% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -41.10% | -181.85% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -41.10% | -181.85% | |||
| EBIT | -26.39% | -0.61% | |||
| EBITDA | -55.76% | 13.79% | |||
| EPS Basic | -4.06% | -150.42% | |||
| Normalized Basic EPS | -993.02% | 129.25% | |||
| EPS Diluted | 0.81% | -162.71% | |||
| Normalized Diluted EPS | -993.02% | 129.25% | |||
| Average Basic Shares Outstanding | 35.77% | 12.28% | |||
| Average Diluted Shares Outstanding | 35.77% | 12.28% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||